Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,283
Total Claims
$1.8M
Drug Cost
525
Beneficiaries
$3,374
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,619 Neuropsychiatry providers
+170%
Cost per patient vs peers
$3,374 vs $1,249 avg
+18%
Brand preference vs peers
6.3% vs 5.4% avg
Brand vs Generic
Brand: 651 claims · $1.1M
Generic: 9,632 claims · $676K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lurasidone Hcl | 174 | $326K |
| Aripiprazole | 94 | $272K |
| Lurasidone Hcl | 315 | $192K |
| Valbenazine Tosylate | 24 | $184K |
| Aripiprazole | 632 | $113K |
| Cariprazine Hcl | 48 | $82K |
| Brexpiprazole | 42 | $65K |
| Divalproex Sodium | 444 | $35K |
| Prazosin Hcl | 314 | $34K |
| Quetiapine Fumarate | 152 | $33K |
| Paliperidone Palmitate | 17 | $30K |
| Quetiapine Fumarate | 647 | $27K |
| Olanzapine | 396 | $23K |
| Vortioxetine Hydrobromide | 26 | $21K |
| Fluphenazine Hcl | 79 | $17K |
Prescribing Profile
62
Unique Drugs
15.0
Anomaly Score
Patient Profile
61
Avg Age
62%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About